Amicus Therapeutics Europe Limited
3 products tracked · names used in filings: Amicus Therapeutics Europe Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Opfolda miglustat | Authorised | 2023-06-26 |
| 🇪🇺 | Pombiliti cipaglucosidase alfa | Authorised | 2023-03-20 |
| 🇪🇺 | Galafold migalastat | Authorised | 2016-05-25 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.